The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy

Journal of Virological Methods

Volumn 223, Issue , 2015, Pages 30-32

  Salimo, Anna T ^a   Ledwaba, Johanna ^a   Coovadia, Ashraf ^b   Abrams, Elaine J ^c   Technau, Karl Günter ^b   Kuhn, Louise ^d   Morris, Lynn ^a,b   Hunt, Gillian M ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Columbia University ^*  (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Children; Dried blood spots; HIV drug resistance genotyping

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; VIRUS DNA;

ALGORITHM; AMPLICON; ANTIVIRAL RESISTANCE; ARTICLE; DRIED BLOOD SPOT TESTING; GENOTYPE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS MUTATION; BLOOD; DESICCATION; EVALUATION STUDY; GENETICS; GENOTYPING TECHNIQUE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; PROCEDURES; SOUTH AFRICA; SPECIMEN HANDLING; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BLOOD; CHILD, PRESCHOOL; DESICCATION; DRUG RESISTANCE, VIRAL; GENOTYPING TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; SOUTH AFRICA; SPECIMEN HANDLING;

EID: 84938337063     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.07.005     Document Type: Article

References (16)

1. Bertagnolio S., Parkin N.T., Jordan M., Brooks J., Garcia-Lerma J.G. Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev. 2010, 12:195-208.
2. Department of Health The South African Antiretroviral Treatment Guidelines 2013.
3. Fitzgerald F., Penazzato M., Gibb D. Development of antiretroviral resistance in children with HIV in low- and middle-income countries. J. Infect. Dis. 2013, 207(Suppl. 2):S85-S92.
4. Goga A. Effectiveness of the National Prevention of Mother-to-Child Transmission (PMTCT) Programme in South Africa: 2011 National SAPMTCT Survey Results 2012.
5. Hunt G.M., Coovadia A., Abrams E.J., Sherman G., Meyers T., Morris L., Kuhn L. HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine. Aids 2011, 25:1461-1469.
6. Johannessen A., Holberg-Petersen M., Lovgaarden G., Naman E., Ormaasen V., Matee M.I., Gundersen S.G., Bruun J.N. HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania. Antivir. Ther. 2010, 15:1003-1009.
7. Kuhn L., Hunt G., Technau K.G., Coovadia A., Ledwaba J., Pickerill S., Penazzato M., Bertagnolio S., Mellins C.A., Black V., Morris L., Abrams E.J. Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis. Aids 2014, 28:1673-1678.
8. Monleau M., Aghokeng A.F., Eymard-Duvernay S., Dagnra A., Kania D., Ngo-Giang-Huong N., Toure-Kane C., Truong L.X., Chaix M.L., Delaporte E., Ayouba A., Peeters M., Group A.S. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia. J. Clin. Microbiol. 2014, 52:578-586.
9. Pillay V., Ledwaba J., Hunt G., Rakgotho M., Singh B., Makubalo L., Bennett D.E., Puren A., Morris L. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Antivir. Ther. 2008, 13(Suppl. 2):101-107.
10. Rottinghaus E.K., Ugbena R., Diallo K., Bassey O., Azeez A., Devos J., Zhang G., Aberle-Grasse J., Nkengasong J., Yang C. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy. Clin. Infect. Dis. 2012, 54:1187-1195.
11. Sherman G.G., Lilian R.R., Bhardwaj S., Candy S., Barron P. Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa. S. Afr. Med. J. 2014, 104:235-238.
12. Wei X., Youngpairoj A.S., Garrido C., Zahonero N., Corral A., de Mendoza C., Heneine W., Johnson J.A., Garcia-Lerma J.G. Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance. J. Clin. Virol. 2011, 50:148-152.
13. World Health Organization Global Update on HIV Treatment 2013: Results, Impact and Opportunities. WHO Report in Partnership With UNICEF and UNAIDS 2013.
14. Woods C.K., Brumme C.J., Liu T.F., Chui C.K., Chu A.L., Wynhoven B., Hall T.A., Trevino C., Shafer R.W., Harrigan P.R. Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. J. Clin. Microbiol. 2012, 50:1936-1942.
15. Zhou Z., Wagar N., DeVos J.R., Rottinghaus E., Diallo K., Nguyen D.B., Bassey O., Ugbena R., Wadonda-Kabondo N., McConnell M.S., Zulu I., Chilima B., Nkengasong J., Yang C. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings. PLoS ONE 2011, 6:e28184.
16. Ziemniak C., Mengistu Y., Ruff A., Chen Y.H., Khaki L., Bedri A., Simen B.B., Palumbo P., Eshleman S.H., Persaud D. Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings. J. Clin. Microbiol. 2011, 49:4077-4082.